ZVRA Stock Earnings: Zevra Therapeutics Misses EPS, Beats Revenue for Q4 2023 : vimarsana.com

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ZVRA stock results show that Zevra Therapeutics missed analyst estimates for earnings per share…

Related Keywords

, Market News , Stock Advice , Zevra Therapeutics , Zevra Therapeutics Misses , Beats Revenue , News , Ggregator , Reaking News , Uration , Edia ,